Vericel Corp (VCEL)
44.73
-1.38
(-2.99%)
USD |
NASDAQ |
Apr 25, 11:00
Vericel Cash from Operations (Quarterly): 10.09M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.09M |
| September 30, 2023 | 7.169M |
| June 30, 2023 | 10.20M |
| March 31, 2023 | 7.86M |
| December 31, 2022 | 6.975M |
| September 30, 2022 | 4.101M |
| June 30, 2022 | 3.143M |
| March 31, 2022 | 3.468M |
| December 31, 2021 | 10.55M |
| September 30, 2021 | 3.634M |
| June 30, 2021 | 4.769M |
| March 31, 2021 | 10.09M |
| December 31, 2020 | 11.34M |
| September 30, 2020 | 4.57M |
| June 30, 2020 | -3.021M |
| March 31, 2020 | 4.686M |
| December 31, 2019 | 3.15M |
| September 30, 2019 | 7.892M |
| June 30, 2019 | -18.38M |
| March 31, 2019 | 0.154M |
| December 31, 2018 | 2.611M |
| September 30, 2018 | 2.013M |
| June 30, 2018 | -5.441M |
| March 31, 2018 | 0.405M |
| December 31, 2017 | 0.834M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.241M |
| June 30, 2017 | -5.654M |
| March 31, 2017 | -3.122M |
| December 31, 2016 | -9.308M |
| September 30, 2016 | -4.182M |
| June 30, 2016 | -5.133M |
| March 31, 2016 | -1.269M |
| December 31, 2015 | -4.037M |
| September 30, 2015 | -0.718M |
| June 30, 2015 | -4.478M |
| March 31, 2015 | -4.113M |
| December 31, 2014 | -6.244M |
| September 30, 2014 | -8.423M |
| June 30, 2014 | -6.069M |
| March 31, 2014 | -4.674M |
| December 31, 2013 | -4.343M |
| September 30, 2013 | -4.139M |
| June 30, 2013 | -4.70M |
| March 31, 2013 | -6.761M |
| December 31, 2012 | -7.338M |
| September 30, 2012 | -7.654M |
| June 30, 2012 | -7.95M |
| March 31, 2012 | -6.603M |
| December 31, 2011 | -6.144M |
| September 30, 2011 | -6.14M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.38M
Minimum
Jun 2019
11.34M
Maximum
Dec 2020
4.856M
Average
4.769M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -17.29M |
| Chimerix Inc | -14.59M |
| Karyopharm Therapeutics Inc | -18.58M |
| Axsome Therapeutics Inc | -30.36M |
| Y-mAbs Therapeutics Inc | -8.036M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.088M |
| Cash from Financing (Quarterly) | 1.307M |
| Free Cash Flow | 7.798M |
| Free Cash Flow Per Share (Quarterly) | 0.0471 |
| Free Cash Flow to Equity (Quarterly) | 2.251M |
| Free Cash Flow to Firm (Quarterly) | 2.251M |
| Free Cash Flow Yield | 0.37% |